On March 5, 2024, analyst Maria Ripps from Canaccord Genuity reaffirmed a Hold rating for Viant Technology (NASDAQ:DSP) and increased...
Gain Therapeutics has recently shared groundbreaking data on the potential of GT-02287 to halt the progression of Parkinson's disease by...
CASI Pharmaceuticals announced exciting progress on March 5, 2024, with the release of favorable interim Phase 1 findings for BI-1206...
On March 5, 2024, Alnylam and Roche announced the launch of the KARDIA-3 Phase 2 trial. This study will assess...
Myers Industries has experienced a notable surge of 13% in its stock price since announcing better-than-expected Q4 adjusted EPS results...
On March 5, 2024, analyst Linda Bolton Weiser from DA Davidson reiterated her positive outlook on WD-40 (NASDAQ: WDFC), maintaining...
LAVA Therapeutics has just hit a major milestone in its partnership with Pfizer on the advancement of PF-08046052. This accomplishment...
AeroVironment's stock is soaring after a stellar performance in Q3 and an optimistic outlook for fiscal year 2024. Revenue in...
Albemarle's stock took a hit today as news of a proposed public offering of depositary shares was announced. The company...
On March 5, 2024, Guggenheim analyst John Heinbockel reiterated his positive stance on Dollar Tree (NASDAQ: DLTR) by maintaining a...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com